Celtic Therapeutics backs UK cancer drug developer

Spirogen Limited raises almost £10m in fight against ovarian cancer

1 October 2009•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.